Clinical Trial Update: A Study of CIN-107 in Adults With Treatment-Resistant Hypertension (rHTN) [Phase 2]

View source ↗

Summary

Phase 2 trial of CIN-107 in adults with treatment-resistant hypertension has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Resistant Hypertension

Drugs mentioned

• CIN-107

Snippet

Sponsor: CinCor Pharma, Inc. | Conditions: Resistant Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2023-06-28